Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1

Acta Myologica

Volumn 33, Issue 2, 2015, Pages 104-106

  Russo, Vincenzo ^a   Nigro, Gerardo ^a   Papa, Andrea Antonio ^a   Rago, Anna ^a   Della Cioppa, Nadia ^b   Cristiano, Anna ^a   Russo, Maria Giovanna ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b MONALDI HOSPITAL   (Italy)

Author keywords

Adenosine; Myotonic Dystrophy; Proarrhythmic effect; Sinus tachycardia

Indexed keywords

ADENOSINE; ANTIARRHYTHMIC AGENT;

ADENOSINE INDUCED SINUS TACHYCARDIA; ADULT; ARTICLE; ATRIOVENTRICULAR CONDUCTION; BLOOD PRESSURE MEASUREMENT; CASE REPORT; DRUG INDUCED DISEASE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGICAL PROCEDURES; HEART ATRIOVENTRICULAR NODE; HEART MUSCLE REFRACTORY PERIOD; HEART PALPITATION; HUMAN; MALE; MYOTONIC DYSTROPHY; OXYGEN SATURATION; PHYSICAL EXAMINATION; QRS COMPLEX; SINUS RHYTHM; SINUS TACHYCARDIA; CHEMICALLY INDUCED; COMPLICATION; HEART FUNCTION TEST; PATHOPHYSIOLOGY;

ADENOSINE; ADULT; ANTI-ARRHYTHMIA AGENTS; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; MALE; MYOTONIC DYSTROPHY; TACHYCARDIA, SINUS;

EID: 84942252299     PISSN: 11282460     EISSN: 25321900     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Russo AD, Mangiola F, Della Bella P, et al. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study. J Cardiovasc Med (Hagerstown) 2009;10:51-8.
2. Cudia P, Bernasconi P, Chiodelli R, et al. Risk of arrhythmia in type I myotonic dystrophy: The role of clinical and genetic variables. J Neurol Neurosurg Psych 2009;80:790-3.
3. Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995;25:746-52.
4. Buja G, Miorelli M, Turrini P, et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993;72:973-6.
5. Nigro G, Russo V, Rago A, et al. Heterogeneity of ventricular repolarization in newborns with severe aortic coarctation. Pediatr Cardiol 2012;33:302-6.
6. Nigro G, Russo V, Rago A, et al. The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short term follow up study. Physiol Res 2014;63:27-33.
7. Russo V, Rago A, Pannone B, et al. Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death. Eur J Haematol 2011;86:324-31.
8. Nigro G, Russo V, Rago A, et al. Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. Kardiol Pol 2012;70:1154-9.
9. Nigro G, Russo V, Di Salvo G, et al. Increased heterogenity of ventricular repolarization in obese nonhypertensive children. Pacing Clin Electrophysiol 2010;33:1533-9.
10. Russo V, Ammendola E, De Crescenzo I, et al. Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. Obes Surg 2007;17:857-65.
11. Santangelo L, Ammendola E, Russo V, et al. Influence of biventricular pacing on myocardial dispersion of repolarization in dilated cardiomyopathy patients. Europace 2006;8:502-5.
12. Russo V, Rago A, Politano L, et al. Increased dispersion of ventricular repolarization in Emery Dreifuss muscular dystrophy patients. Med Sci Monit 2012;18: CR643-7.
13. Nigro G, Russo V, Rago A, et al. Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. Kardiol Pol 2012;70:1154-9.
14. Nigro G, Nigro G, Politano L, et al. Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients Heart 2002;87:156-7.
15. Rotundo IL, Faraso S, De Leonibus E et al. Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy. PLoS One. 2011;6:e24729. doi: 10.1371/journal.pone.0024729. Epub 2011 Sep. 9.
16. Vitiello C, Faraso S, Sorrentino NC, et al. Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments. PLoS One 2009;4:e5051. doi: 10.1371/journal.pone.0005051. Epub 2009 Mar. 31.
17. Drury AN, Szent-Györgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 1929;68:213-37.
18. Belhassen B, Fish R, Viskin S, et al. Adenosine-5'-triphosphate test for the noninvasive diagnosis of concealed accessory pathway. J Am Coll Cardiol 2000;36:803-10.
19. Mallet ML. Proarrhythmic effects of adenosine: a review of the literature. Emerg Med J 2004;21:408-10.
20. Pelleg A, Pennock RS, Kutalek SP. Proarrhythmic effects of adenosine: one decade of clinical data. Am J Ther 2002;9:141-7.
21. Tan HL, Spekhorst HH, Peters RJ, et al. Adenosine induced ventricular arrhythmias in the emergency room. Pacing Clin Electrophysiol 2001;24:450-5.
22. Prystowski EN, Naccarelli GV, Jackman WM, et al. Enhanced parasympathetic tone shortens atrial refractoriness in man. Am J Cardiol 1983;51:96-100.
23. Slade AK, Garratt CJ. Proarrhythmic effect of adenosine in a patient with atrial flutter. Br Heart J 1993;70:91-2.
24. Rankin AC, Rae AP, Houston A. Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J 1993;69:263-3.
25. Vora A, Lokhandwala Y. Adenosine-induced tachycardia: what is the mechanism? J Cardiovasc Electrophysiol 2000;11:491-2.
26. Orebaugh SL, Handy M. Intravenous adenosine therapy accelerating rate of paroxysmal supraventricular tachycardia. Am J Emerg Med 1992;10:326-30.
27. Watt AH, Routledge PA. Transient bradycardia and subsequent sinus tachycardia produced by intravenous adenosine in healthy adult subjects. Br J Clin Pharmacol 1986;21:533-6.
28. Biaggioni I, Killian TJ, Mosqueda-Garcia R et al. Adenosine increases sympathetic nerve traffic in humans. Circulation 1991;83:1668-75.